Vor Biopharma (VOR) Current Leases (2020 - 2026)
Vor Biopharma (VOR) posted quarterly Current Leases of $307000.0 for Q1 2026, down 92.8% year-over-year from $4.3 million in Q1 2025, and up 9.64% quarter-over-quarter from $280000.0 in Q4 2025.
Vor Biopharma (VOR) Current Leases (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has reported Current Leases for 7 consecutive years, with $307000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases fell 92.8% year-over-year to $307000.0; the TTM figure through Mar 2026 stood at $307000.0 (down 92.8% YoY), while the FY2025 annual figure was $280000.0, down 93.36% from the prior year.
- Current Leases advanced to $307000.0 in Q1 2026 per VOR's latest filing, from $280000.0 in the prior quarter.
- Across five years, Current Leases topped out at $7.3 million in Q1 2022 and bottomed at $252000.0 in Q3 2025.
- Historically, Current Leases has averaged $3.5 million across 5 years, with a median of $3.8 million in 2022.
- Annual changes were most pronounced in 2022 — Current Leases surged 530.39% — and 2025, when it slumped 93.95%.
- Vor Biopharma's Current Leases stood at $3.3 million in 2022, then grew by 17.05% to $3.8 million in 2023, then rose by 10.05% to $4.2 million in 2024, then plunged by 93.36% to $280000.0 in 2025, then grew by 9.64% to $307000.0 in 2026.
- Business Quant data shows VOR's Current Leases at $307000.0 in Q1 2026, $280000.0 in Q4 2025, and $252000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Vor Biopharma | 1.36 Bn | 1.36 Bn | - | 335,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 335,000.00 |
| Mar 31, 2026 | 307,000.00 |
| Dec 31, 2025 | 280,000.00 |
| Sep 30, 2025 | 252,000.00 |
| Mar 31, 2025 | 4.27 Mn |
| Dec 31, 2024 | 4.22 Mn |
| Sep 30, 2024 | 4.16 Mn |
| Jun 30, 2024 | 4.11 Mn |
| Mar 31, 2024 | 3.96 Mn |
| Dec 31, 2023 | 3.83 Mn |
| Sep 30, 2023 | 3.74 Mn |
| Jun 30, 2023 | 3.69 Mn |
| Mar 31, 2023 | 3.71 Mn |
| Dec 31, 2022 | 3.27 Mn |
| Sep 30, 2022 | 3.76 Mn |
| Jun 30, 2022 | 4.43 Mn |
| Mar 31, 2022 | 7.28 Mn |
| Dec 31, 2021 | 1.84 Mn |
| Sep 30, 2021 | 1.15 Mn |
| Jun 30, 2021 | 1.16 Mn |